Company Filing History:
Years Active: 2003
Title: Harry Drabkin: Innovator in Neurite Growth and Cancer Research
Introduction
Harry Drabkin is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of cellular biology, particularly in the area of neurite growth and cancer research. His innovative work focuses on methods that can potentially inhibit cancer cell metastasis and promote neurite growth and regeneration.
Latest Patents
Drabkin holds a patent for a "Method for identifying neurite-growth promoting agents." This invention provides methods for identifying and utilizing compounds that modulate cell motility. The implications of this patent are profound, as it relates to the repellent-receptor signaling pathway that controls cellular attachment and detachment to a substratum.
Career Highlights
Harry Drabkin is affiliated with the University of Colorado, where he continues to advance research in his field. His work has garnered attention for its potential applications in treating cancer and enhancing nerve regeneration.
Collaborations
Drabkin has collaborated with esteemed colleagues such as Karl Pfenninger and Becky De La Houssaye. Their combined expertise contributes to the innovative research being conducted at the University of Colorado.
Conclusion
In summary, Harry Drabkin is a pioneering inventor whose work in identifying neurite-growth promoting agents holds promise for significant advancements in medical science. His contributions to cancer research and cellular biology are noteworthy and continue to inspire further exploration in these critical areas.